Arrowstreet Capital, Limited Partnership Ironwood Pharmaceuticals Inc Transaction History

Arrowstreet Capital, Limited Partnership

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$8.32 - $15.45 $93,433 - $173,503	11,230 Added 6.82%	175,777 $1.53 Million
Q4 2023 Feb 14, 2024	BUY	$8.79 - $11.51 $427,703 - $560,053	48,658 Added 41.99%	164,547 $1.88 Million
Q3 2023 Nov 14, 2023	BUY	$8.25 - $11.35 $763,323 - $1.05 Million	92,524 Added 395.99%	115,889 $1.12 Million
Q2 2023 Aug 14, 2023	BUY	$10.1 - $11.6 $235,986 - $271,034	23,365 New	23,365 $249,000
Q1 2022 May 13, 2022	SELL	$10.61 - $12.88 $2.92 Million - $3.55 Million	-275,640 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $5 Million - $6.42 Million	-460,081 Reduced 62.53%	275,640 $3.21 Million
Q3 2021 Nov 12, 2021	BUY	$11.92 - $13.92 $8.77 Million - $10.2 Million	735,721 New	735,721 $9.61 Million
Q1 2021 May 14, 2021	SELL	$9.04 - $11.86 $3.39 Million - $4.44 Million	-374,569 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$9.05 - $12.2 $3.39 Million - $4.57 Million	374,569 New	374,569 $4.27 Million
Q3 2020 Nov 12, 2020	SELL	$8.99 - $10.74 $256,655 - $306,616	-28,549 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$9.14 - $11.97 $122,923 - $160,984	13,449 Added 89.07%	28,549 $295,000
Q1 2020 May 15, 2020	SELL	$8.58 - $14.01 $4 Million - $6.54 Million	-466,524 Reduced 96.86%	15,100 $152,000
Q4 2019 Feb 13, 2020	BUY	$8.22 - $14.0 $3.96 Million - $6.74 Million	481,624 New	481,624 $6.41 Million

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $530M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.